论文部分内容阅读
目的:探讨介入动脉化疗栓塞治疗鼻咽癌的临床价值。方法:将87例鼻咽癌患者分成3组:1)A组(介入化疗+放疗组)26例;2)B组(放疗+化疗组)29例;3)C组(单纯放疗组)32例。结果:随访48-61个月,近期疗效CR分别为A组80.8％、B组58.6％、C组50.0％,A组与B、c组分别比较,差异均有显著性(P<0.05);2、3、4年生存率分别为:A组80.8％、76.9％、61.5％,B组58.6％、51.7％、44.8％,C组46.9％、40.6％、37.5％。结论:采用放疗结合介入化疗栓塞对鼻咽癌治疗有协同作用,值得临床推广应用。
Objective: To investigate the clinical value of interventional arterial chemoembolization in the treatment of nasopharyngeal carcinoma. Methods: 87 patients with NPC were divided into 3 groups: 1) group A (interventional chemotherapy + radiotherapy group); group B (radiotherapy + chemotherapy group); group C example. Results: The follow - up of 48-61 months showed that the short - term treatment effect was 80.8% in group A, 58.6% in group B and 50.0% in group C, respectively. The difference was significant between group A and group B and c (P <0.05). The 2, 3, 4 year survival rates were 80.8%, 76.9%, 61.5% in group A, 58.6%, 51.7%, 44.8% in group B, 46.9%, 40.6%, 37.5% in group C, respectively. Conclusion: Radiotherapy combined with interventional chemotherapy and embolization has a synergistic effect on the treatment of nasopharyngeal carcinoma, which is worthy of clinical application.